Larotrectinib (Larotrectinib) A box of 60 tablets can usually be taken for several days. Analysis of the treatment course

Larotrectinib is an oral small molecule targeted drug mainly used to treat patients with NTRK gene fusion-positive solid tumors. Its mechanism of action is to highly selectively inhibit TRK kinase activity, thereby blocking abnormal signaling of tumor cells, inhibiting tumor growth and inducing apoptosis. As a precision treatment drug, larotrectinib is suitable for patients with solid tumors of various tissue origins and can be used as long-term oral maintenance therapy.

According to the recommended dosage in the instructions, adult patients usually take 100mg twice a day. The specific dosage needs to be adjusted according to weight, condition and tolerance. If calculated based on this dose, a box of 60 tablets of larotrectinib can last approximately 30 days of treatment. Children or patients with low body weight may need to adjust the dose based on body surface area or weight, and the corresponding number of days of treatment will also be different. Therefore, the medication plan needs to be arranged reasonably under the guidance of a professional doctor.

In terms of price, larotrectinib is currently on the market in China and is included in medical insurance. Patients can purchase it at domestic pharmacies. The price of the original medicine is relatively high, about about 20,000 yuan per box. For specific medical insurance reimbursement ratios, you need to consult the local hospital pharmacy. For patients with long-term treatment or limited financial affordability, overseas generic drugs provide a more economical option. For example, the Laos version of generic drugs only costs a few hundred yuan to more than a thousand yuan per box. Its drug ingredients are basically the same as the original drugs, which can reduce the economic burden while ensuring the efficacy.

Clinically, patients should strictly abide by medical instructions when using larotrectinib, and regularly monitor blood routine, liver and kidney function, and imaging indicators to evaluate efficacy and safety. At the same time, attention should be paid to the correct way of taking the drug, and try to keep the drug at a fixed time on an empty stomach or with meals to maintain stable blood drug concentration. By rationally arranging treatment courses and choosing appropriate drug purchase channels, patients can better balance affordability while ensuring therapeutic efficacy.

Reference link:https://www.drugs.com